First Line Drug Therapy for Type 2 Diabetes
Listen now
Description
Dr. Centor discusses the cost-effectiveness of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in the treatment of patients with type 2 diabetes with Drs. Neda Laiteerapong and Aaron Winn.
More Episodes
Dr. Centor discusses the adverse events associated with checkpoint inhibitors with Drs. Reaford Blackburn Jr. and Brian C. Westbrook.
Published 04/15/24
Published 04/15/24
Dr. Centor discusses how to go beyond statistical significance testing when interpreting study findings with Dr. David Savitz.
Published 04/01/24
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
